Abstract
Anemia occurs with high incidence in patients affected by chronic renal failure (CRF) [1], Many factors have been described as being responsible for the anemic status in these patients [2-5]. Erythropoietin deficiency seems to be the main cause of anemia in CRF [6]. Blood transfusions are frequently needed to counteract this complication, with the risk of hepatitis, AIDS, iron overload, and sensitization of hystocompatibility antigens, with reduction in the success probability rates for renal transplantation [7]. Nowadays, the possibility of having sufficient amounts of human erythropoietin, produced by DNA-recombinant methods (rHuEPO) [8, 9] has made the therapeutic use of this compound available for the treatment of anemia in CRF patients [7, 10-14].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eschbach JW (1983) Hematologic problems of dialysis patients. In: Drukker W, Parson FM, Mäher JF (eds) Replacement of renal function by dialysis. Nijhoff, Boston, pp 630–645
Eschbach JW, Adamson JW (1985) Anemia of end-stage renal disease ( ESRD ). Kidney Int 28: 1
Adamson JW, Eschbach JW, Finch CA (1968) The kidney and erythropoiesis. Am J Med 44: 725
Jacobson LO, Goldwasser E, Fried W, Plzak L (1957) Role of the kidney in erythropoiesis. Nature 179: 633
Caro J, Brown S, Miller O, Murray T, Erslev AJ (1979) Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 93: 449
Erslev A J (1969) Erythropoietin function of the kidney. In: Wesson LG (ed) Physiology of the human kidney. Grune and Stratton, New York, pp 521–534
Winearls CG, Pippard MJ, Downing MR etal. (1986) Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet ii: 1175
Jacobs K, Shoemaker C, Roudersdorf R et al. (1985) Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 313: 806
Lin FK, Suggs S, Lin CH et al. (1985) Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 82: 7580
Eschbach JW, Egrie JC, Downing MR et al. (1987) Correction of the anaemia of end stage renal disease with recombinant human erythropoietin. N Engl J Med 316: 73
Eschbach JW, Adamson JW (1988) Recombinant human erythropoietin: implications for nephrology. Am J Kidney Dis 3: 203
Casati S, Passerini P, Campise MR, Graziani G, Cesana B, Perisic M, Ponticelli C (1988) Benefici e rischi del trattamento protratto con eritropoietina umana ricombinante in pazienti emodializzati. Br Med J (Ital Edn) 8: 104
Schaefer RM, Hörl WH, Massry SG (1989) Treatment of renal anaemia with recombinant human erythropoietin. Am J Nephrol 9: 353
Ponticelli C, Casati S (1989) Correction of anaemia with recombinant human erythropoietin. Nephron 52: 201
Hermanek P, Sobin LH (eds) (1987) TNM classification of malignant tumors. Springer, Berlin Heidelberg New York
Stone WJ, Graber SE, Krantz SB et al. (1988) Treatment of the anaemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial. Am J Med Sci 296: 171
Koene RAP (1988) Recombinant human erythropoietin in predialysis patients: results from Belgium and the Netherlands. Dialysis and Transplantation 17: 639
Lim VS, De Gowin RL, Zavala D et al. (1989) Recombinant human erythropoietin treatment in pre-dialysis patients. Ann Intern Med 110: 108
Eschbach JW, Kelly MR, Haley NR et al. (1989) Treatment of the anaemia of progressive renal failure with recombinant human erythropoietin. N Eng J Med 321: 158
Kleinman KS, Schweitzer SU, Perdue ST (1989) The use of recombinant human erythropoietin in the correction of anaemia in predialysis patients and its effects on renal function: a double-blind, placebo-controlled trial. Am J Kidney Dis 6: 486
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Di Benedetto, A., Nuzzi, F., Sorice, P. (1992). Erythropoietin Effects on Acute Anemia Induced by Antineoplastic Therapy in the Case of a Uremic Patient with Lymphoma. In: Pagel, H., Weiss, C., Jelkmann, W. (eds) Pathophysiology and Pharmacology of Erythropoietin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77074-6_36
Download citation
DOI: https://doi.org/10.1007/978-3-642-77074-6_36
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77076-0
Online ISBN: 978-3-642-77074-6
eBook Packages: Springer Book Archive